Harper’s Bazaar has published a powerful new piece by Chris Tilberis, who serves on OCRA’s Board of Directors, reflecting on his mother Liz Tilberis’ remarkable career as the former editor-in-chief … Continued
As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovarian and … Continued
Help OCRA Make an Impact for Ovarian Cancer and Gynecologic Cancer Awareness Month September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. As the largest non-profit in the … Continued
Last month, we updated you on the U.S. House of Representatives’ progress on FY2025 appropriations bills, which mostly held good news for programs related to ovarian cancer funding. Those programs … Continued
September is our time to spread the word about ovarian cancer risk and prevention, rally for more scientific research, and make progress toward a cure for ovarian and related gynecologic … Continued
Fortune Magazine Shares OCRA’s Lifesaving Ovarian Cancer Prevention Message In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, and OCRA’s Scientific Advisory Committee member Dr. … Continued
Last month, we updated you on recent reports indicating that the House Committee on Appropriations was considering significant cuts to health-related programs, sparking concerns that these potential cuts could impair … Continued
This article was updated in July 2024 to reflect NCCN’s release of the 2024 Guidelines for Ovarian Cancer Patients. OCRA is a proud sponsor of NCCN’s 2024 Ovarian Cancer Updates … Continued
OCRA’s 2024 Mentored Investigator Grants are supporting fresh perspectives and approaches to end ovarian and related gynecologic cancers. This year’s grants are awarded to 5 exceptional young researchers who are … Continued
In an article titled “Amazon MGM Studios’ Debra Birnbaum Joins Ovarian Cancer Research Alliance Board,” Variety editor William Earl writes about MGM Studios’ Debra Birnbaum’s appointment to Ovarian Cancer Research … Continued
In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, spoke with Fortune Magazine about why knowing risk and taking preventative action can save lives, and … Continued
Amazon MGM Studios’ Debra Birnbaum, Media Visionary & Ovarian Cancer Survivor, Joins OCRA Board of Directors Ovarian Cancer Research Alliance is proud to announce that Debra Birnbaum has joined its Board … Continued
Get email updates about research news, action alerts, and ways to join the fight.
